RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.
Imaging Powerhouse | RadNet's strategic acquisitions and AI-driven solutions position it as a leader in outpatient diagnostic imaging, with impressive revenue growth and market expansion |
Financial Resilience | Despite challenges, RadNet outperformed expectations, raising guidance and maintaining strong liquidity, signaling management's confidence in future growth |
AI-Driven Innovation | Explore RadNet's DeepHealth suite, offering competitive advantages in speed and usability, potentially revolutionizing healthcare imaging and diagnostic processes |
Analyst Optimism | Barclays maintains an Overweight rating with a $60 price target, reflecting confidence in RadNet's growth trajectory and market position |
Metrics to compare | RDNT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRDNTPeersSector | |
---|---|---|---|---|
P/E Ratio | −126.8x | −0.1x | −0.5x | |
PEG Ratio | 0.53 | 0.01 | 0.00 | |
Price/Book | 4.6x | 0.9x | 2.6x | |
Price / LTM Sales | 2.2x | 1.1x | 3.3x | |
Upside (Analyst Target) | 40.9% | 43.6% | 43.5% | |
Fair Value Upside | Unlock | 14.3% | 6.8% | Unlock |